JP2014052322A - Analysis method of physiologically active substance contained in hair - Google Patents
Analysis method of physiologically active substance contained in hair Download PDFInfo
- Publication number
- JP2014052322A JP2014052322A JP2012198042A JP2012198042A JP2014052322A JP 2014052322 A JP2014052322 A JP 2014052322A JP 2012198042 A JP2012198042 A JP 2012198042A JP 2012198042 A JP2012198042 A JP 2012198042A JP 2014052322 A JP2014052322 A JP 2014052322A
- Authority
- JP
- Japan
- Prior art keywords
- hair
- physiologically active
- analysis method
- active substance
- ims
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004209 hair Anatomy 0.000 title claims abstract description 83
- 238000004458 analytical method Methods 0.000 title claims abstract description 25
- 239000013543 active substance Substances 0.000 title claims abstract description 24
- 238000001871 ion mobility spectroscopy Methods 0.000 claims abstract description 21
- 239000000126 substance Substances 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims description 22
- 239000002117 illicit drug Substances 0.000 claims description 3
- 238000001269 time-of-flight mass spectrometry Methods 0.000 claims description 3
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 27
- 229960002715 nicotine Drugs 0.000 description 27
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 27
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000003814 drug Substances 0.000 description 10
- 230000003699 hair surface Effects 0.000 description 9
- 238000003384 imaging method Methods 0.000 description 8
- 230000008014 freezing Effects 0.000 description 7
- 238000007710 freezing Methods 0.000 description 7
- 239000011521 glass Substances 0.000 description 7
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 231100000640 hair analysis Toxicity 0.000 description 5
- 239000013076 target substance Substances 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- -1 etc.) Proteins 0.000 description 4
- 230000003696 hair cross section Effects 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000012472 biological sample Substances 0.000 description 3
- 229960003920 cocaine Drugs 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 229960001252 methamphetamine Drugs 0.000 description 3
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 3
- 239000004081 narcotic agent Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000000021 stimulant Substances 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 238000004506 ultrasonic cleaning Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- NZNMSOFKMUBTKW-UHFFFAOYSA-N Cyclohexanecarboxylic acid Natural products OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- AFVLVVWMAFSXCK-VMPITWQZSA-N alpha-cyano-4-hydroxycinnamic acid Chemical compound OC(=O)C(\C#N)=C\C1=CC=C(O)C=C1 AFVLVVWMAFSXCK-VMPITWQZSA-N 0.000 description 2
- 239000000599 controlled substance Substances 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 210000000720 eyelash Anatomy 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 238000001254 matrix assisted laser desorption--ionisation time-of-flight mass spectrum Methods 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 239000000941 radioactive substance Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000000278 spinal cord Anatomy 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 description 1
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- SHXWCVYOXRDMCX-UHFFFAOYSA-N 3,4-methylenedioxymethamphetamine Chemical compound CNC(C)CC1=CC=C2OCOC2=C1 SHXWCVYOXRDMCX-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 231100000742 Plant toxin Toxicity 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 229940039750 aconitine Drugs 0.000 description 1
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 231100000659 animal toxin Toxicity 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 102000003675 cytokine receptors Human genes 0.000 description 1
- 108010057085 cytokine receptors Proteins 0.000 description 1
- 229960002069 diamorphine Drugs 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- IWJBVMJWSPZNJH-UQGZVRACSA-N ethyl glucuronide Chemical compound CCO[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O IWJBVMJWSPZNJH-UQGZVRACSA-N 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 150000002327 glycerophospholipids Chemical class 0.000 description 1
- 230000003695 hair diameter Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000000752 ionisation method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 240000004308 marijuana Species 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- FIKAKWIAUPDISJ-UHFFFAOYSA-L paraquat dichloride Chemical compound [Cl-].[Cl-].C1=C[N+](C)=CC=C1C1=CC=[N+](C)C=C1 FIKAKWIAUPDISJ-UHFFFAOYSA-L 0.000 description 1
- CEOCDNVZRAIOQZ-UHFFFAOYSA-N pentachlorobenzene Chemical compound ClC1=CC(Cl)=C(Cl)C(Cl)=C1Cl CEOCDNVZRAIOQZ-UHFFFAOYSA-N 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000003123 plant toxin Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229940001470 psychoactive drug Drugs 0.000 description 1
- 239000004089 psychotropic agent Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- CFMYXEVWODSLAX-QOZOJKKESA-N tetrodotoxin Chemical compound O([C@@]([C@H]1O)(O)O[C@H]2[C@@]3(O)CO)[C@H]3[C@@H](O)[C@]11[C@H]2[C@@H](O)N=C(N)N1 CFMYXEVWODSLAX-QOZOJKKESA-N 0.000 description 1
- 229950010357 tetrodotoxin Drugs 0.000 description 1
- CFMYXEVWODSLAX-UHFFFAOYSA-N tetrodotoxin Natural products C12C(O)NC(=N)NC2(C2O)C(O)C3C(CO)(O)C1OC2(O)O3 CFMYXEVWODSLAX-UHFFFAOYSA-N 0.000 description 1
- 229910052716 thallium Inorganic materials 0.000 description 1
- BKVIYDNLLOSFOA-UHFFFAOYSA-N thallium Chemical compound [Tl] BKVIYDNLLOSFOA-UHFFFAOYSA-N 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- JOFWLTCLBGQGBO-UHFFFAOYSA-N triazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1Cl JOFWLTCLBGQGBO-UHFFFAOYSA-N 0.000 description 1
- 229960003386 triazolam Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Landscapes
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
Abstract
Description
本発明は、毛髪中の生理活性物質のイメージング技術に関する。 The present invention relates to an imaging technique for physiologically active substances in hair.
従来、毛髪中の薬物・嗜好品等の測定は、数十本の毛髪から対象物質を抽出・濃縮後、クロマトグラフィー/質量分析計にて定量測定されて来た。しかし、その測定結果は非連続/一定期間平均値であり、外部汚染/受動摂取の可能性を完全に回避する事はできなかった。 Conventionally, measurement of drugs, luxury products, etc. in hair has been quantitatively measured with a chromatography / mass spectrometer after extracting and concentrating the target substance from several tens of hairs. However, the measurement result was a discontinuous / average value for a certain period, and the possibility of external contamination / passive intake could not be completely avoided.
特許文献1は、毛髪を溶媒抽出して毛髪中の生理活性物質を分析する方法を記載する。 Patent document 1 describes the method of analyzing the physiologically active substance in hair by solvent-extracting hair.
非特許文献1は、毛髪中のメタアンフェタミンのバーコード状の分析を記載する。 Non-Patent Document 1 describes a barcode-like analysis of methamphetamine in hair.
非特許文献2は、毛髪中のコカインの分析を記載する。 Non-Patent Document 2 describes the analysis of cocaine in hair.
特許文献1は、非連続かつ定性的な化学物質の分析のみが可能である。 Patent Document 1 can only analyze discontinuous and qualitative chemical substances.
非特許文献1,2によれば、毛髪中のメタアンフェタミン、コカインなどのバーコード状の分析は可能であるが、定量的な分析はできないので、違法薬物使用の証拠として不十分であった。 According to Non-Patent Documents 1 and 2, barcode-like analysis of methamphetamine, cocaine, and the like in hair is possible, but quantitative analysis is not possible, so that it is insufficient as evidence of illegal drug use.
本発明は、毛髪中の生理活性物質を使用時期と使用量を特定できる分析技術を提供することを目的とする。 An object of this invention is to provide the analysis technique which can specify the use time and the usage-amount of the physiologically active substance in hair.
本発明は、以下の毛髪の解析方法を提供するものである。
項1. 毛髪中に蓄積された生理活性物質の解析方法であって、以下の工程
工程1:毛髪を長軸方向にスライスし、髄質を露出させる工程
工程2:工程1で露出した表面に内部標準物質を適用する工程
工程3:工程2で得られた表面についてイメージング質量分析(IMS)を行い、毛髪中の生理活性物質を連続的かつ定量的に検出する工程
を含むことを特徴とする、毛髪中に蓄積された生理活性物質の解析方法。
項2. 前記生理活性物質が違法薬物である、項1に記載の解析方法。
項3. IMSがMALDI−TOFMSを用いて行われる、項1又は2に記載の解析方法。
項4. 工程1の毛髪のスライスをミクロトームにより行う、項1〜3のいずれかに記載の解析方法。
項5. 工程1の毛髪のスライスを凍結及び固定された毛髪に対して行う、項1〜4のいずれかに記載の解析方法。
項6. IMSが走査型IMSである項1〜5のいずれかに記載の解析方法。
The present invention provides the following hair analysis method.
Item 1. A method for analyzing physiologically active substances accumulated in hair, comprising the following steps: Step 1: slicing hair in the long axis direction to expose medulla Step 2: Internal standard substance on the surface exposed in Step 1 Applying Step 3: Performing imaging mass spectrometry (IMS) on the surface obtained in Step 2, and continuously and quantitatively detecting the physiologically active substance in the hair. Analysis method of accumulated physiologically active substance.
Item 2. Item 2. The analysis method according to Item 1, wherein the physiologically active substance is an illegal drug.
Item 3. Item 3. The analysis method according to Item 1 or 2, wherein the IMS is performed using MALDI-TOFMS.
Item 4. Item 4. The analysis method according to any one of Items 1 to 3, wherein the hair is sliced by a microtome.
Item 5. Item 5. The analysis method according to any one of Items 1 to 4, wherein the hair slice in Step 1 is performed on the frozen and fixed hair.
Item 6. Item 6. The analysis method according to any one of Items 1 to 5, wherein the IMS is a scanning IMS.
本発明によれば、ミクロトームなどの装置を用いて毛髪を長軸方向にスライスすることで、毛髪中の生理活性物質を解析できるため、毛髪試料の作製が迅速であり、再現性もよい。生理活性物質の解析に白髪、染毛、くせ毛、長さ、太さなどの毛髪の性状は無関係であり、表面の汚染物質の影響を受けない。 According to the present invention, since a physiologically active substance in hair can be analyzed by slicing hair in the long axis direction using a device such as a microtome, the preparation of a hair sample is quick and reproducibility is good. The properties of hair such as gray hair, dyed hair, comb hair, length, and thickness are irrelevant to the analysis of physiologically active substances, and are not affected by surface contaminants.
毛髪の空間的解像度は約50μmであり、これは毛髪の2〜3時間の成長に相当する。すなわち、生理活性物質の連続的な解析を2〜3時間単位で行うことができ、麻薬、覚醒剤などの違法薬物の使用履歴を正確に反映させることができ、裁判においても十分な証拠能力を有する。 The spatial resolution of the hair is about 50 μm, which corresponds to a 2-3 hour growth of the hair. In other words, continuous analysis of physiologically active substances can be performed in units of 2 to 3 hours, and the use history of illegal drugs such as narcotics and stimulants can be accurately reflected, and there is sufficient evidence capacity in trials. .
本発明で解析される生理活性物質は、違法薬物、医薬品、嗜好品(ニコチン等)など生体外から摂取する化学物質に限らず、生体内タンパク質/ペプチド/脂質/核酸などが含まれ、毛髪中に蓄積し得る生理活性物質を広く解析することができる。 The physiologically active substances analyzed in the present invention are not limited to chemical substances taken from outside the body such as illegal drugs, pharmaceuticals, and luxury products (nicotine, etc.), but include in vivo proteins / peptides / lipids / nucleic acids, etc. It is possible to widely analyze physiologically active substances that can accumulate in
本発明は、試料として毛髪の超薄切断面を使用し、手段として質量イメージング(IMS)を組み合わせることで毛髪内に存在・蓄積した生理活性物質の連続追跡を可能にする。 The present invention enables continuous tracking of physiologically active substances present and accumulated in hair by using an ultra-thin cut surface of hair as a sample and combining mass imaging (IMS) as a means.
毛髪は、毛髄質(メデュラ)の周囲にコルテックス領域、さらに最外層にキューティクル領域がある。本発明の方法において、毛髪は、毛髄質(メデュラ)が露出するまでキューティクル領域とコルテックス領域を長軸方向にスライスする。この操作の前に毛髪の表面に付着した汚染物質を洗浄するための洗浄工程を行ってもよいが、毛髪表面に付着した汚染物質は、毛髪の表面をスライスするときに同時に除かれるので、毛髪の洗浄操作は必ずしも行う必要はない。 Hair has a cortex area around the medulla and a cuticle area on the outermost layer. In the method of the present invention, the hair slices the cuticle region and cortex region in the longitudinal direction until the medulla is exposed. Before this operation, a washing process for washing the contaminants attached to the hair surface may be performed. However, since the contaminants attached to the hair surface are removed at the same time when slicing the hair surface, the hair is removed. It is not always necessary to perform the washing operation.
毛髪の長軸方向のスライス工程は、ミクロトームを用いて行うことができる。ミクロトームとしては、例えばガラスナイフを装着したミクロトームが例示できる。毛髪をスライスする装置はミクロトームに限定されず、毛髪を非常に薄くスライスできる装置であれば全て使用可能である。本発明では毛髪中の生理活性物質を連続的かつ定量的に解析するので、スライスは高精度で行い、毛髪の髄質の部分が均質にスライス表面に露出していることが好ましい。 The long-axis slicing step of hair can be performed using a microtome. Examples of the microtome include a microtome equipped with a glass knife. The apparatus for slicing hair is not limited to a microtome, and any apparatus that can slice hair very thinly can be used. In the present invention, since the physiologically active substance in the hair is analyzed continuously and quantitatively, it is preferable that the slicing is performed with high accuracy and the medullary portion of the hair is uniformly exposed on the slice surface.
毛髪のスライス操作は、凍結させた毛髪をミクロトームなどに固定して行うのが好ましい。毛髪をパラフィンなどに包埋後にミクロトームを使用すると、IMSの際にパラフィンなどのピークが強く出るため、目的物質の定量が難しくなる。 The hair slicing operation is preferably performed by fixing the frozen hair to a microtome or the like. When a microtome is used after embedding hair in paraffin or the like, peaks of paraffin or the like appear strongly during IMS, making it difficult to quantify the target substance.
次に毛髄質(メデュラ)が露出した毛髪に対し、標識された内部標準物質を含む溶液を噴霧などによりアプライした後、イメージング質量分析(IMS)を行う。IMSは、走査型IMSが好ましい。内部標準物質の標識は、13Cにより好ましく行うことができるが、15N、17Oなどの他の安定同位体により標識した内部標準物質を用いてもよい。標識された内部標準物質は、MALDIなどのマトリクス支援レーザーイオン化方法を用いる場合には、マトリクスと一緒にスライスした毛髪にアプライすることが好ましい。 Next, a solution containing a labeled internal standard substance is applied to the hair from which the medulla (medulla) is exposed by spraying or the like, and then imaging mass spectrometry (IMS) is performed. The IMS is preferably a scanning type IMS. The internal standard substance can be labeled preferably with 13 C, but an internal standard substance labeled with other stable isotopes such as 15 N and 17 O may be used. The labeled internal standard is preferably applied to the hair sliced with the matrix when using a matrix-assisted laser ionization method such as MALDI.
IMSで、毛髪中の目的物質と標識された目的物質の比を求めることで、目的物質の定量を行うことができる。 The target substance can be quantified by determining the ratio of the target substance in the hair to the labeled target substance by IMS.
毛髪は50μm成長するのに2〜3時間かかり、1mmでは40〜60時間、20mmでは800〜1200時間(約33日〜50日)の生理活性物質の使用の履歴を解析できるため、違法薬物を含む嗜好品/医薬品等の使用履歴を立証できる。また、毛髪内に移行・蓄積する生理活性物質であれば、連続的/経時的に定量することができる。その結果、疾患起因/関連分子が生体内でどの程度の量でどの程度の期間存在したのかについても解析できる。 It takes 2-3 hours for hair to grow 50 μm, and it is possible to analyze the history of the use of physiologically active substances for 40 to 60 hours at 1 mm and 800 to 1200 hours (about 33 to 50 days) at 20 mm. It is possible to verify the usage history of luxury products / pharmaceuticals. Any physiologically active substance that migrates and accumulates in the hair can be quantified continuously / over time. As a result, it is possible to analyze how much and for how long the disease-causing / related molecule has existed in the living body.
本発明に使用する試料としてはヒトの頭髪が最も好ましいが、頭髪以外の体毛(陰毛、脇毛、睫毛、眉毛、髭など)や、牛、馬、犬、猫、マウス、ラットなどの動物毛も「毛髪」に含まれる。本発明は、1本の毛髪で毛髪中の生理活性物質を十分に定量及び連続的に解析することができる。 Human hair is most preferable as a sample used in the present invention, but hair other than head hair (pubic hair, armpit hair, eyelashes, eyebrows, eyelashes, etc.) and animal hair such as cows, horses, dogs, cats, mice, rats, etc. Included in “hair”. The present invention can sufficiently quantitate and continuously analyze a physiologically active substance in hair with a single hair.
本発明により解析可能な毛髪中の物質は、特に限定されないが、例えば、覚せい剤、麻薬、向精神薬、違法薬物、スポーツドーピング規制薬物、あるいはその他の薬物、特に法規制薬物もしくはその代謝物、タンパク質(酵素、ホルモン、受容体、サイトカインなど)、ペプチド(ホルモンなど)、脂質(中性脂肪、ワックス、セラミド、リン脂質、スフィンゴリン脂質、グリセロリン脂質、スフィンゴ糖脂質、グリセロ糖脂質、リポタンパク質、スルホ脂質、テルペノイド、ステロイドなど)が例示される。また、農薬、動植物毒物、環境汚染物質、有害元素、放射性物質、その他の有害物質や毒物も例示される。より具体的には、たとえば、覚せい剤であるメタンフェタミンおよびアンフェタミン、麻薬であるMDMA、MDA、モルヒネ、コカインおよびヘロイン、大麻成分であるTHC、医薬品であるトリアゾラムおよびジアゼパム、スポーツドーピング禁止薬物であるテストステロン、メタノール摂取の指標となるエチルグルクロニド、農薬であるメソミル、MEPおよびパラコート、動植物毒であるテトロドトキシンおよびアコニチン、環境汚染物質であるダイオキシン、PCBおよびベンゼン、有害元素であるヒ素、水銀、鉛およびタリウム、化学兵器や放射性物質、ニコチンなどのその他の有害物質、並びにこれらの代謝物等が挙げられる。 Substances in hair that can be analyzed according to the present invention are not particularly limited, for example, stimulants, narcotics, psychotropic drugs, illegal drugs, sports doping controlled drugs, or other drugs, particularly legally controlled drugs or metabolites thereof, Protein (enzyme, hormone, receptor, cytokine, etc.), peptide (hormone, etc.), lipid (neutral fat, wax, ceramide, phospholipid, sphingophospholipid, glycerophospholipid, sphingoglycolipid, glyceroglycolipid, lipoprotein, Sulfolipids, terpenoids, steroids and the like) are exemplified. Moreover, agricultural chemicals, animal and plant toxicants, environmental pollutants, harmful elements, radioactive substances, and other harmful substances and toxic substances are also exemplified. More specifically, for example, stimulants methamphetamine and amphetamine, narcotics MDMA, MDA, morphine, cocaine and heroin, cannabis components THC, pharmaceuticals triazolam and diazepam, sports doping-inhibiting drugs testosterone, Ethyl glucuronide as an indicator of methanol intake, pesticides mesomil, MEP and paraquat, animal and plant toxins tetrodotoxin and aconitine, environmental pollutants dioxin, PCB and benzene, harmful elements arsenic, mercury, lead and thallium, chemical Examples include weapons, radioactive substances, other toxic substances such as nicotine, and metabolites thereof.
以下、実施例により本発明をさらに詳細に説明する。
実施例1
(1)毛髪表面の洗浄
毛髪(2cm程度)を栓付き試験管に入れ、
1)0.5%SDS溶液中で1分間超音波洗浄後、SDS溶液を吸引
2)精製水中で1分間超音波洗浄後、精製水を吸引
3)メタノールで1分間超音波洗浄後、メタノールを吸引
4)2)→3)を2回繰り返す
5)洗浄毛髪を試験管より取り出し、キムワイプ上で乾燥
Hereinafter, the present invention will be described in more detail with reference to examples.
Example 1
(1) Washing the hair surface Put the hair (about 2cm) into a test tube with a stopper,
1) After ultrasonic cleaning in 0.5% SDS solution for 1 minute, aspirate SDS solution
2) After ultrasonic cleaning for 1 minute in purified water, aspirate purified water
3) After ultrasonic cleaning with methanol for 1 minute, aspirate methanol
4) Repeat 2) → 3) twice
5) Remove the washed hair from the test tube and dry on the Kimwipe
(2)毛髪処理法
1) スポンジ研磨材による剥離法(従来法)
*洗浄毛髪の両端を固定し、スポンジ研磨材(住友スリーエム(株):超極細目#1500)で実体顕微鏡下、観察しながら表面キューティクルを擦り取る(25回程度)。
*髄が顕微鏡下で確認出来た時点で終了し、湿らせた脱脂綿等で表面のゴミを軽く拭き取る。
*ITOスライドガラス(Bruker Daltonics社:237001)に導電性両面テープ(日東電工(株):No.5601)を張り付け、その上に擦り面が上になる様に毛髪をしっかり固定し、IMS解析に供する。
2) ミクロトームによる超薄切法(本発明法)
*洗浄毛髪を導電性両面テープ(日東電工(株):No.5601)に張り付け、ガラススライドに固定し、生物試料凍結ユニット((株)日本ミクロトーム研究所)を用いて毛髪を氷結(-20℃)させる。
*生物試料凍結ユニットを実体顕微鏡付き手動式ミクロトームシステム((株)日本ミクロトーム研究所)取り付け-20℃下、ガラスナイフにて2μm毎凍結毛髪を削いで行く。
*実体顕微鏡で観察しながら髄が出現した時点で、終了する。平均ヒト毛髪直径を100μmと仮定すると、25サイクル(2μm×25=50μm)すればよい。
*終了後、生物試料凍結ユニットを室温に戻し、導電性両面テープ上の水滴を軽く拭き取った後、ユニットからガラススライドを取り外す。
*ガラススライド上の導電性両面テープを慎重に剥がし、ITOスライドガラスに移し、IMS解析に供する。
(2) Hair treatment method
1) Peeling method using sponge abrasive (conventional method)
* Fix both ends of the washed hair, and scrape the surface cuticle with a sponge abrasive (Sumitomo 3M Co., Ltd .: Superfine # 1500) while observing under a stereomicroscope (about 25 times).
* Finish when the spinal cord is visible under the microscope, and lightly wipe off the dust on the surface with moistened absorbent cotton.
* Attach conductive double-sided tape (Nitto Denko Corporation: No.5601) to ITO glass slide (Bruker Daltonics: 237001), and fix the hair firmly so that the rubbing surface is on top for IMS analysis. Provide.
2) Ultra-thin cutting method by microtome (invention method)
* Washed hair is affixed to a conductive double-sided tape (Nitto Denko Corporation: No.5601), fixed to a glass slide, and frozen using a biological sample freezing unit (Japan Microtome Research Laboratories) ° C).
* Attach a biological sample freezing unit with a manual microtome system with a stereomicroscope (Japan Microtome Research Laboratories Co., Ltd.).
* End when the spinal cord appears while observing with a stereomicroscope. Assuming that the average human hair diameter is 100 μm, 25 cycles (2 μm × 25 = 50 μm) may be used.
* After completion, return the biological sample freezing unit to room temperature, gently wipe off the water droplets on the conductive double-sided tape, and then remove the glass slide from the unit.
* Carefully remove the conductive double-sided tape on the glass slide, transfer it to an ITO glass slide, and use it for IMS analysis.
(3)毛髪断面走査定量質量イメージング解析法
1) MALDI-TOFMS機器
使用機器:Autoflex speed(Bruker Daltonics社製smart beamII)
SRM定量解析:モニターイオンはParent ion:163.2>Fragment ion:132.2
NCはm/z=132.2、13C3-NCはm/z=135.2をモニターし、132.2/135.2のピーク高さ比より定量する。
2) マトリックス
αシアノ-4-ヒドロキシ安息香酸(CHCA: SIGMA社製c2020、Lot No:MKBH1245V)を0.2%トリフルオロ酢酸/50%アセトニトリル溶媒にて7mg/mLに調整し、ImagePrepTM(Bruker Daltonics社製)にて毛髪断面に噴霧する。
3) 内部標準物質
13C3-NC(CIL社:CLM-3914-0.1)のメタノール溶液を希釈し、上記CHCA溶液に終濃度50ng/mL添加し、マトリックスと共に毛髪断面上に噴霧する。
4) ImagePrep操作
Bruker Daltonics社指定のファイル「HCCA_nsh05」にて噴霧操作を実施。
5) 定量計算
毛髪1cm長(=0.04mm3)のピーク高さ比から「pg/mg Hair」値を算出
計算式=(132/135)x 25 x 50
(3) Hair cross section scanning quantitative mass imaging analysis method
1) MALDI-TOFMS equipment Equipment used: Autoflex speed (Bruker Daltonics smart beamII)
SRM quantitative analysis: Monitor ion is Parent ion: 163.2> Fragment ion: 132.2
NC is monitored at m / z = 132.2, 13 C 3 -NC is monitored at m / z = 135.2, and quantified from the peak height ratio of 132.2 / 135.2.
2) Matrix α-Cyano-4-hydroxybenzoic acid (CHCA: SIGMA c2020, Lot No: MKBH1245V) was adjusted to 0.2 mg trifluoroacetic acid / 50% acetonitrile solvent to 7 mg / mL, and ImagePrep TM (Bruker Daltonics) To the hair cross section.
3) Internal standard substance
A methanol solution of 13 C 3 -NC (CIL: CLM-3914-0.1) is diluted, added to the CHCA solution at a final concentration of 50 ng / mL, and sprayed onto the hair cross section with the matrix.
4) ImagePrep operation
Spraying operation was performed with the file “HCCA_nsh05” specified by Bruker Daltonics.
5) Quantitative calculation Calculate the “pg / mg hair” value from the peak height ratio of 1 cm long hair (= 0.04 mm 3 ) Formula = (132/135) x 25 x 50
(4) 結果
1)本法でのNC値の再現性 (長期喫煙者毛髪:>30本/日、>20年間)
9.5 +/- 1.2 ng/mg Hair
34.5 +/- 2.8 ng/mg Hair CV =10%前後
2)従来法との比較: NC溶液(0.1、1.0 μg/mL)を添加した非喫煙者毛髪
本法:0.22、0.36 ng/mg (従来法:0.21 ng/mg)
0.60、1.13 ng/mg (従来法:0.97 ng/mg)
3)3処理法(未処理、スポンジ研磨材による剥離法、ミクロトームによる超薄切法)での比較(図3) 試料毛髪:NC 1.0μg/mL添加毛髪
未処理法 : 0.23 ng/mg
剥離法 : 0.58 ng/mg
超薄切法 : 1.13 ng/mg
結果を表1及び図1〜3に示す。
(4) Results
1) Reproducibility of NC value by this method (long-term smoker hair:> 30 / day,> 20 years)
9.5 +/- 1.2 ng / mg Hair
34.5 +/- 2.8 ng / mg Hair CV = around 10%
2) Comparison with conventional method: Non-smoker's hair with NC solution (0.1, 1.0 μg / mL) This method: 0.22, 0.36 ng / mg (Conventional method: 0.21 ng / mg)
0.60, 1.13 ng / mg (conventional method: 0.97 ng / mg)
3) Comparison of 3 treatment methods (untreated, exfoliation method with sponge abrasive, ultra-thin cutting method with microtome) (Figure 3) Sample hair: Hair with NC added at 1.0μg / mL Untreated method: 0.23 ng / mg
Peeling method: 0.58 ng / mg
Ultra-thin cutting method: 1.13 ng / mg
The results are shown in Table 1 and FIGS.
Table I. 15名のヘビースモーカーと7名の非喫煙者の長さ方向にスライスした毛髪サンプルにおけるNC含量 (ng/mg hair) Table I. NC content (ng / mg hair) in hair samples sliced along the length of 15 heavy smokers and 7 non-smokers
(5) 考察
今回、標識安定同位体を内部標準に用い、毛髪断面走査定量イメージング解析法を新規開発し、喫煙者毛髪中ニコチン(NC)定量に応用した。本法は、毛髪表面のキューティクル層をガラスナイフ付きミクロトームにて剥ぎ落とし、NC特有のMSイオン(m/z=163/132)を指標に毛髪断面(超薄切)上を連続走査することで時間毎/数ヶ月間NC値の連続追跡が出来き、更に標識安定同位体(13C3-NC:m/z=166/135)を内部標準とし、高精度・高感度定量測定が可能となった。
(5) Discussion This time, we developed a new hair cross-sectional scanning quantitative imaging analysis method using labeled stable isotope as an internal standard and applied it to the determination of nicotine (NC) in smoker hair. In this method, the cuticle layer on the hair surface is peeled off with a microtome with a glass knife, and the hair cross section (ultra thin slice) is continuously scanned using the MS ions (m / z = 163/132) peculiar to NC as an index. NC value can be continuously tracked every hour / month, and labeled stable isotope ( 13 C 3 -NC: m / z = 166/135) is used as an internal standard, enabling highly accurate and sensitive quantitative measurement. became.
本法は、NC以外に医薬品・嗜好品・補助食品・化粧品等、非生体分子からタンパク質・ペプチド・糖質・脂質などの生体分子までその応用範囲は広く、更に人毛以外に実験動物体毛にも適用可能。 This method has a wide range of applications from non-biomolecules to biomolecules such as proteins, peptides, carbohydrates, and lipids in addition to NC, such as pharmaceuticals, luxury products, supplements, and cosmetics. Is also applicable.
Claims (6)
工程1:毛髪を長軸方向にスライスし、髄質を露出させる工程
工程2:工程1で露出した表面に内部標準物質を適用する工程
工程3:工程2で得られた表面についてイメージング質量分析(IMS)を行い、毛髪中の生理活性物質を連続的かつ定量的に検出する工程
を含むことを特徴とする、毛髪中に蓄積された生理活性物質の解析方法。 A method for analyzing physiologically active substances accumulated in hair, comprising the following steps: Step 1: slicing hair in the long axis direction to expose medulla Step 2: Internal standard substance on the surface exposed in Step 1 Applying Step 3: Performing imaging mass spectrometry (IMS) on the surface obtained in Step 2, and continuously and quantitatively detecting the physiologically active substance in the hair. Analysis method of accumulated physiologically active substance.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012198042A JP6029391B2 (en) | 2012-09-10 | 2012-09-10 | Method for analyzing physiologically active substances contained in hair |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012198042A JP6029391B2 (en) | 2012-09-10 | 2012-09-10 | Method for analyzing physiologically active substances contained in hair |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014052322A true JP2014052322A (en) | 2014-03-20 |
JP6029391B2 JP6029391B2 (en) | 2016-11-24 |
Family
ID=50610909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012198042A Active JP6029391B2 (en) | 2012-09-10 | 2012-09-10 | Method for analyzing physiologically active substances contained in hair |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6029391B2 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017519976A (en) * | 2014-06-12 | 2017-07-20 | ザ プロクター アンド ギャンブル カンパニー | Detection and demonstration of thermal damage to hair by peptide evaluation |
WO2018030409A1 (en) * | 2016-08-12 | 2018-02-15 | 株式会社オーガンテクノロジーズ | Health-level measuring method, health-level determining apparatus, and hair-health diagnosis system |
CN108072691A (en) * | 2016-11-17 | 2018-05-25 | 中国科学院大连化学物理研究所 | A kind of method of Etomidate in quick, sensitive detection blood |
CN108871947A (en) * | 2018-04-23 | 2018-11-23 | 广州质量监督检测研究院 | Hair product high temperature-proof damages the evaluation method of effect |
WO2018235914A1 (en) * | 2017-06-23 | 2018-12-27 | シャープ株式会社 | Measurement method, measurement kit, and measurement device |
WO2019181677A1 (en) * | 2018-03-20 | 2019-09-26 | シャープ株式会社 | Hair treatment method, measurement method, fixture, and sample |
WO2019216264A1 (en) * | 2018-05-10 | 2019-11-14 | シャープ株式会社 | Hair sample jig |
KR20200077020A (en) * | 2018-12-20 | 2020-06-30 | 한국과학기술연구원 | Method for monitoring residues on hair evidences by using secondary ion mass spectrometry and sample preparation |
JP2021085870A (en) * | 2019-11-26 | 2021-06-03 | 厦門歴思科技服務有限公司 | Novel method of detecting human-ingested substances and ingestion times |
JP2021096219A (en) * | 2019-12-17 | 2021-06-24 | 厦門歴思科技服務有限公司 | Monitoring method based on detection of ingested substance of human body |
CN113125546A (en) * | 2020-11-06 | 2021-07-16 | 郑州安图生物工程股份有限公司 | Hair mass spectrum detection chip and hair rapid identification method |
JP2021117127A (en) * | 2020-01-27 | 2021-08-10 | 株式会社ワイエイシイダステック | Apparatus for cutting thread and method for cutting the same |
WO2022064819A1 (en) * | 2020-09-28 | 2022-03-31 | 国立大学法人大阪大学 | Method for obtaining information about components included in hair |
WO2022239460A1 (en) * | 2021-05-13 | 2022-11-17 | 国立大学法人大阪大学 | Method for analyzing biomolecule in hair |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5910419A (en) * | 1997-05-06 | 1999-06-08 | Johnson; Ted Donald | Method for forensically screening hair samples for the presence of cannabinoids |
JP2007056010A (en) * | 2005-07-28 | 2007-03-08 | Mandom Corp | Damage-repairing agent for hair |
JP2008191134A (en) * | 2007-02-01 | 2008-08-21 | Naohisa Miyazaki | Laser ablation mass spectrometer |
US20120220039A1 (en) * | 2009-11-05 | 2012-08-30 | The Hong Kong University Of Science And Technology | Method and system for detecting residual poison in human body |
-
2012
- 2012-09-10 JP JP2012198042A patent/JP6029391B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5910419A (en) * | 1997-05-06 | 1999-06-08 | Johnson; Ted Donald | Method for forensically screening hair samples for the presence of cannabinoids |
JP2007056010A (en) * | 2005-07-28 | 2007-03-08 | Mandom Corp | Damage-repairing agent for hair |
JP2008191134A (en) * | 2007-02-01 | 2008-08-21 | Naohisa Miyazaki | Laser ablation mass spectrometer |
US20120220039A1 (en) * | 2009-11-05 | 2012-08-30 | The Hong Kong University Of Science And Technology | Method and system for detecting residual poison in human body |
Non-Patent Citations (4)
Title |
---|
JPN6014009261; 内藤 康秀: '「生体試料を対象にした質量顕微鏡」' Journal of the Mass Spectrometry Society of Japan Vol. 53, No. 3, 20050601, p. 125-132, 日本質量分析学会 * |
JPN6014009261; 内藤 康秀: '「生体試料を対象にした質量顕微鏡」' Journal of the Mass Spectrometry Society of Japan Vol. 53, No. 3, 20050601, pp. 125-132, 日本質量分析学会 * |
JPN6016015773; Akihiro Miki et al.: '"MALDI-TOF and MALDI-FTICR imaging mass spectrometry of methamphetamine incorporated into hair"' Journal of Mass Spectrometry Vol. 46, No. 4, 201104, p. 411-416 * |
JPN6016015774; Tiffany Porta et al.: '"Single Hair Cocaine Consumption Monitoring by Mass Spectrometric Imaging"' Analytical Chemistry Vol. 83, No. 11, 20110601, p. 4266-4272, American Chemical Society * |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017519976A (en) * | 2014-06-12 | 2017-07-20 | ザ プロクター アンド ギャンブル カンパニー | Detection and demonstration of thermal damage to hair by peptide evaluation |
JP7082347B2 (en) | 2016-08-12 | 2022-06-08 | 株式会社オーガンテクノロジーズ | Health measurement method, health judgment device and hair health diagnosis system |
WO2018030409A1 (en) * | 2016-08-12 | 2018-02-15 | 株式会社オーガンテクノロジーズ | Health-level measuring method, health-level determining apparatus, and hair-health diagnosis system |
JPWO2018030409A1 (en) * | 2016-08-12 | 2019-07-25 | 株式会社オーガンテクノロジーズ | Health degree measuring method, health degree judging device and hair health examination system |
CN108072691A (en) * | 2016-11-17 | 2018-05-25 | 中国科学院大连化学物理研究所 | A kind of method of Etomidate in quick, sensitive detection blood |
WO2018235914A1 (en) * | 2017-06-23 | 2018-12-27 | シャープ株式会社 | Measurement method, measurement kit, and measurement device |
WO2019181677A1 (en) * | 2018-03-20 | 2019-09-26 | シャープ株式会社 | Hair treatment method, measurement method, fixture, and sample |
CN108871947A (en) * | 2018-04-23 | 2018-11-23 | 广州质量监督检测研究院 | Hair product high temperature-proof damages the evaluation method of effect |
WO2019216264A1 (en) * | 2018-05-10 | 2019-11-14 | シャープ株式会社 | Hair sample jig |
KR20200077020A (en) * | 2018-12-20 | 2020-06-30 | 한국과학기술연구원 | Method for monitoring residues on hair evidences by using secondary ion mass spectrometry and sample preparation |
KR102157348B1 (en) * | 2018-12-20 | 2020-09-18 | 한국과학기술연구원 | Method for monitoring residues on hair evidences by using secondary ion mass spectrometry and sample preparation |
JP2021085870A (en) * | 2019-11-26 | 2021-06-03 | 厦門歴思科技服務有限公司 | Novel method of detecting human-ingested substances and ingestion times |
JP7116122B2 (en) | 2019-11-26 | 2022-08-09 | 厦門歴思科技服務有限公司 | A novel method for detecting substances ingested by the human body and frequency of ingestion |
JP7050118B2 (en) | 2019-12-17 | 2022-04-07 | 厦門歴思科技服務有限公司 | Monitoring method based on the detection of substances ingested by the human body |
JP2021096219A (en) * | 2019-12-17 | 2021-06-24 | 厦門歴思科技服務有限公司 | Monitoring method based on detection of ingested substance of human body |
JP2021117127A (en) * | 2020-01-27 | 2021-08-10 | 株式会社ワイエイシイダステック | Apparatus for cutting thread and method for cutting the same |
WO2022064819A1 (en) * | 2020-09-28 | 2022-03-31 | 国立大学法人大阪大学 | Method for obtaining information about components included in hair |
CN113125546A (en) * | 2020-11-06 | 2021-07-16 | 郑州安图生物工程股份有限公司 | Hair mass spectrum detection chip and hair rapid identification method |
CN113125546B (en) * | 2020-11-06 | 2023-04-07 | 郑州安图生物工程股份有限公司 | Hair mass spectrum detection chip and hair rapid identification method |
WO2022239460A1 (en) * | 2021-05-13 | 2022-11-17 | 国立大学法人大阪大学 | Method for analyzing biomolecule in hair |
Also Published As
Publication number | Publication date |
---|---|
JP6029391B2 (en) | 2016-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6029391B2 (en) | Method for analyzing physiologically active substances contained in hair | |
Yuan et al. | Solid-phase microextraction fiber in face mask for in vivo sampling and direct mass spectrometry analysis of exhaled breath aerosol | |
Garden et al. | Heterogeneity within MALDI samples as revealed by mass spectrometric imaging | |
Ly et al. | High-mass-resolution MALDI mass spectrometry imaging of metabolites from formalin-fixed paraffin-embedded tissue | |
Klampfl et al. | Direct ionization methods in mass spectrometry: An overview | |
Kamata et al. | Time-course mass spectrometry imaging for depicting drug incorporation into hair | |
Lin et al. | Paper spray-MS for bioanalysis | |
Seeley et al. | Molecular imaging of proteins in tissues by mass spectrometry | |
Soini et al. | In situ surface sampling of biological objects and preconcentration of their volatiles for chromatographic analysis | |
US20140264004A1 (en) | Systems and methods for analyzing a sample using a mass spectrometry probe configured to contact the sample | |
Cuypers et al. | Consequences of decontamination procedures in forensic hair analysis using metal-assisted secondary ion mass spectrometry analysis | |
Power et al. | Analysis of nectar from low‐volume flowers: A comparison of collection methods for free amino acids | |
Ryan et al. | Protein identification in imaging mass spectrometry through spatially targeted liquid micro‐extractions | |
Gu et al. | Direct analysis of biological samples using extractive electrospray ionization mass spectrometry (EESI-MS) | |
Kempson et al. | ToF-SIMS analysis of elemental distributions in human hair | |
Nimesh et al. | Current status and future perspectives of mass spectrometry imaging | |
JP2005519669A (en) | Micro apparatus for biological tissue examination and analysis method | |
Zhang et al. | Detection of methamphetamine and its main metabolite in fingermarks by liquid chromatography–mass spectrometry | |
Rodil et al. | Selective extraction of trace levels of polychlorinated and polybrominated contaminants by supercritical fluid-solid-phase microextraction and determination by gas chromatography/mass spectrometry. Application to aquaculture fish feed and cultured marine species | |
Kamata et al. | High spatial-resolution matrix-assisted laser desorption/ionization-ion trap-time-of-flight tandem mass spectrometry imaging for depicting longitudinal and transverse distribution of drugs incorporated into hair | |
Wang et al. | Sensitive residue analysis of quinolones and sulfonamides in aquatic product by capillary zone electrophoresis using large-volume sample stacking with polarity switching combined with accelerated solvent extraction | |
Fang et al. | Drug monitoring by volumetric absorptive microsampling: method development considerations to mitigate hematocrit effects | |
Mandal et al. | Development of sheath-flow probe electrospray ionization mass spectrometry and its application to real time pesticide analysis | |
Martin et al. | Sampling and characterisation of volatile organic compound profiles in human saliva using a polydimethylsiloxane coupon placed within the oral cavity | |
Li et al. | Robotic surface analysis mass spectrometry (RoSA-MS) of three-dimensional objects |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150814 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160428 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160510 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160704 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160822 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160927 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20161018 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6029391 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |